Off-Label Use of Anticancer Drugs in South Korea

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2394
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Medical Liability for Off Label Use of Drugs in Romania

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2018English

Off-Label Use of Approved Drugs: Therapeutic Opportunity and Challenges

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2004English

«Off Label Use»: Nouvelles Recommandations

Bulletin des Médecins Suisses
2007English

PND7 Off-Label Use of Antiepileptic Drugs and Its Costs – A Drug Utilization Study in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

Off-Label Use of Omalizumab in Pediatric Anaphylaxis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

Off-Label Use in Lymphoma Patients in Switzerland

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy